Álvaro Aranguren Ibáñez

Clinical Study Manager and CMC Project Manager at AELIX Therapeutics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Barcelona, Catalonia, Spain, ES
Languages
  • Español Native or bilingual proficiency
  • Inglés Full professional proficiency
  • Catalán Full professional proficiency
  • Francés Elementary proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Course in Training Research Staff Users of Animals for Experimentation and other Scientific Ends
    Generalitat de Catalunya
    Aug, 2011
    - Nov, 2024

Experience

    • Spain
    • Biotechnology Research
    • 1 - 100 Employee
    • Clinical Study Manager and CMC Project Manager
      • May 2023 - Present

      Desarrollando vacunas para encontrar una cura funcional para la infección por VIH.

    • CSM Junior and Project Manager
      • Oct 2021 - May 2023

      CSM Junior and CMC Project Manager. Developing new vaccines to cure HIV.

    • Spain
    • Biotechnology Research
    • 1 - 100 Employee
    • CMC project manager and Clinical Operations trainee
      • May 2021 - Aug 2021

    • Postdoctoral Research Scientist
      • Oct 2015 - Dec 2020

      Postdoctoral researcher in Microtubule function and cell division group. We are mainly focused on understanding the role of the microtubule network in cell organization and function and unraveling how the self-organization of cellular components results in the morphogenesis of dynamic molecular machines. Our final aim is to understand the mechanisms of cell division in order to develop new strategies and treatments oriented to improve antitumoral therapies. Postdoctoral researcher in Microtubule function and cell division group. We are mainly focused on understanding the role of the microtubule network in cell organization and function and unraveling how the self-organization of cellular components results in the morphogenesis of dynamic molecular machines. Our final aim is to understand the mechanisms of cell division in order to develop new strategies and treatments oriented to improve antitumoral therapies.

    • Spain
    • Outsourcing and Offshoring Consulting
    • 200 - 300 Employee
    • Quality Control Manager
      • Feb 2014 - Oct 2015

    • Spain
    • Research Services
    • 300 - 400 Employee
    • PHD Student
      • Oct 2010 - Feb 2014

Education

  • CESIF
    Clinical Trials and Medical Affairs Master, Pharma Industry
    2021 - 2021
  • Universitat de Barcelona
    PhD, Biomedicin
    2011 - 2015
  • Universitat de Barcelona
    Master's degree, Genética humana/médica
    2009 - 2010
  • Universidad de Navarra
    Licenciatura, Bioquímica
    2004 - 2009
  • Universidad de Navarra
    Licenciatura, Biología/Ciencias biológicas, general
    2004 - 2009

Community

You need to have a working account to view this content. Click here to join now